Aliases & Classifications for Corneal Disease

Aliases & Descriptions for Corneal Disease:

Name: Corneal Disease 12 14
Corneal Diseases 52 42 69
Corneal Disorders 41

Classifications:



External Ids:

Disease Ontology 12 DOID:10124
ICD10 33 H18.9 H17.9
ICD9CM 35 371.9
MeSH 42 D003316
NCIt 47 C26731
UMLS 69 C0010034

Summaries for Corneal Disease

MedlinePlus : 41 your cornea is the outermost layer of your eye. it is clear and shaped like a dome. the cornea helps to shield the rest of the eye from germs, dust, and other harmful matter. it also helps your eye to focus. if you wear contact lenses, they float on top of your corneas. problems with the cornea include refractive errors allergies infections injuries dystrophies - conditions in which parts of the cornea lose clarity due to a buildup of cloudy material treatments of corneal disorders include medicines, corneal transplantation, and corneal laser surgery. nih: national eye institute

MalaCards based summary : Corneal Disease, also known as corneal diseases, is related to corneal dystrophy, avellino type and keratitis, and has symptoms including eye manifestations An important gene associated with Corneal Disease is TGFBI (Transforming Growth Factor Beta Induced), and among its related pathways/superpathways is Adhesion. The drugs Ganciclovir and Ranibizumab have been mentioned in the context of this disorder. Affiliated tissues include eye, t cells and testes, and related phenotypes are homeostasis/metabolism and vision/eye

Related Diseases for Corneal Disease

Diseases related to Corneal Disease via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 76)
id Related Disease Score Top Affiliating Genes
1 corneal dystrophy, avellino type 31.3 GSN TGFBI
2 keratitis 10.9
3 keratoconus 10.9
4 corneal dystrophy, fuchs endothelial, 8 10.6
5 corneal dystrophy, fuchs endothelial, 4 10.6
6 meesmann corneal dystrophy 10.6
7 megalocornea 10.6
8 corneal dystrophy, fuchs endothelial, 1 10.6
9 peters anomaly 10.6
10 sclerocornea 10.6
11 corneal dystrophy, fuchs endothelial, 6 10.6
12 band keratopathy 10.6
13 corneal dystrophy, fuchs endothelial, 2 10.5
14 corneal dystrophy, fuchs endothelial, 3 10.5
15 corneal dystrophy, posterior polymorphous, 1 10.5
16 primary syphilis 10.3 TFF1 TFF3
17 dnase1-related susceptibility to systemic lupus erythematosus 10.3 GJB2 GJB6
18 down syndrome-related congenital heart disease 10.3 GJB2 GJB6
19 spastic ataxia, charlevoix-saguenay type 10.3 GJB2 GJB6
20 chronic pulmonary heart disease 10.3 KRT12 KRT3 TGFBI
21 pik3ca-related segmental overgrowth 10.3 GJB2 GJB6
22 bietti crystalline corneoretinal dystrophy 10.3 GJB2 GJB6
23 nut midline carcinoma 10.3 COL8A2 IL1A TGFBI
24 pink1 type of young-onset parkinson disease 10.3 GJB2 GJB6
25 myopathy, myofibrillar, 3 10.3 COL8A2 IL1A TGFBI
26 keratoderma, palmoplantar, with deafness 10.3 GJB2 GJB6
27 corneal dystrophy, posterior polymorphous 2 10.2 COL8A2 SLC4A11 VSX1
28 lymphedema 10.2 IL1A KRT12 KRT3
29 angioedema induced by ace inhibitors 10.2 COL8A2 SLC4A11 VSX1
30 complex partial epilepsy 10.2 KRT12 TGFBI VSX1
31 klumpke paralysis 10.2 GJB2 GJB6
32 malignant visceral pleura tumor 10.2 LCAT NGF
33 enophthalmos 10.2 COL8A2 VSX1
34 pseudomyotonia 10.2 GJB2 GJB6
35 chondrocalcinosis 10.2 COL8A2 SLC4A11 TGFBI VSX1
36 corneal endothelial dystrophy 1, autosomal dominant 10.2 COL8A2 KRT3 SLC4A11 VSX1
37 ectodermal dysplasia 2, clouston type 10.2 GJB2 GJB6
38 congenital herpes simplex 10.2 GJB2 GJB6
39 mixed gonadal dysgenesis 10.2 OPTN TGFB2
40 x-linked nonsyndromic deafness 10.1 GJB2 GJB6 TFF1 TFF3
41 deafness, autosomal recessive 30 10.1 COL8A2 SLC4A11 TGFB2 VSX1
42 epidermolysis bullosa simplex, weber-cockayne type 10.1 CHST6 COL8A2 KRT12 KRT3 TGFBI
43 cervix uteri carcinoma in situ 10.1 GSN TACSTD2 TGFBI
44 idiopathic corneal edema 10.1 COL8A2 OPTN SLC4A11 TGFBI
45 apparent mineralocorticoid excess 10.1 CHST6 KRT12 TGFBI UBIAD1
46 leukemia 10.1 KERA KRT3 VSX1
47 necrotizing ulcerative gingivitis 10.1 CHST6 VSX1
48 chromosome 3q29 microduplication syndrome 10.0 CHST6 KERA TGFBI UBIAD1
49 troyer syndrome 10.0 GJB2 GJB6
50 corneal endothelial dystrophy 10.0 CHST6 KRT12 KRT3 TACSTD2 TGFBI

Graphical network of the top 20 diseases related to Corneal Disease:



Diseases related to Corneal Disease

Symptoms & Phenotypes for Corneal Disease

UMLS symptoms related to Corneal Disease:


eye manifestations

MGI Mouse Phenotypes related to Corneal Disease:

44
id Description MGI Source Accession Score Top Affiliating Genes
1 homeostasis/metabolism MP:0005376 9.8 OPTN SLC4A11 TACSTD2 TFF1 TFF3 TGFB2
2 vision/eye MP:0005391 9.36 CHST6 COL8A2 GJB2 KERA KRT12 LCAT

Drugs & Therapeutics for Corneal Disease

Drugs for Corneal Disease (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 526)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1
Ganciclovir Approved, Investigational Phase 4,Phase 2 82410-32-0 3454
2
Ranibizumab Approved Phase 4,Phase 2,Phase 3,Phase 1 347396-82-1 459903
3
Cyclosporine Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 79217-60-0, 59865-13-3 5284373 6435893
4
Miconazole Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 22916-47-8 4189
5
Dipivefrin Approved Phase 4,Phase 3,Phase 2 52365-63-6 3105
6
Hyaluronic acid Approved, Vet_approved Phase 4,Phase 3,Phase 2 9004-61-9 53477741 24759
7
Acetazolamide Approved, Vet_approved Phase 4 59-66-5 1986
8
Latanoprost Approved, Investigational Phase 4,Phase 3,Phase 2 130209-82-4 5282380 5311221
9
Loteprednol Approved Phase 4,Phase 3,Phase 2 82034-46-6, 129260-79-3 444025 9865442
10
Methylprednisolone Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 83-43-2 6741
11
Prednisolone Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 50-24-8 5755
12
Ephedrine Approved Phase 4,Phase 3,Phase 2,Phase 1 299-42-3 9294
13
Pseudoephedrine Approved Phase 4,Phase 3,Phase 2,Phase 1 90-82-4 7028
14
Glycerol Approved, Experimental Phase 4,Phase 3,Phase 2 56-81-5 753
15
Estradiol Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2 50-28-2 5757 53477783
16
Ethinyl Estradiol Approved Phase 4,Phase 3,Phase 2 57-63-6 5991
17
Levofloxacin Approved, Investigational Phase 4,Phase 3,Phase 1,Phase 2 100986-85-4 149096
18
Moxifloxacin Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 354812-41-2, 151096-09-2 152946
19
Norgestimate Approved Phase 4,Phase 3,Phase 2 35189-28-7 6540478
20
Ofloxacin Approved Phase 4,Phase 3,Phase 1,Phase 2 82419-36-1 4583
21
Bevacizumab Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 216974-75-3
22
Ethanol Approved Phase 4,Phase 2 64-17-5 702
23
Povidone-iodine Approved Phase 4,Phase 3,Phase 2 25655-41-8
24
Zinc Approved Phase 4,Phase 2 7440-66-6 32051 23994
25
Dexamethasone Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2 50-02-2 5743
26
Histamine Approved, Investigational Phase 4,Phase 3 75614-87-8, 51-45-6 774
27
Menthol Approved Phase 4,Phase 3,Phase 2,Early Phase 1 2216-51-5 16666
28
Timolol Approved Phase 4,Phase 3 26839-75-8 33624 5478
29
Lidocaine Approved, Vet_approved Phase 4,Phase 2,Phase 3 137-58-6 3676
30
Betamethasone Approved, Vet_approved Phase 4,Phase 1,Phase 2 378-44-9 9782
31
Natamycin Approved Phase 4,Phase 3,Phase 1,Phase 2 7681-93-8 5281099
32
Fluorometholone Approved Phase 4,Phase 3,Phase 2 426-13-1 9878
33
Epinephrine Approved, Vet_approved Phase 4 51-43-4 5816
34
Doxycycline Approved, Investigational, Vet_approved Phase 4,Phase 2,Phase 3 564-25-0 54671203
35 Titanium dioxide Approved Phase 4 13463-67-7
36
Gabapentin Approved, Investigational Phase 4 60142-96-3 3446
37
Ketorolac Approved Phase 4,Phase 3,Phase 2 74103-06-3, 66635-83-4 3826
38
Azithromycin Approved Phase 4,Phase 3,Phase 2 83905-01-5 55185 53477736 447043
39
Tetracycline Approved, Vet_approved Phase 4 60-54-8 5353990
40
Difluprednate Approved Phase 4,Phase 3,Phase 2 23674-86-4 443936
41
Lansoprazole Approved, Investigational Phase 4 103577-45-3 3883
42
Isotretinoin Approved Phase 4,Phase 2 4759-48-2 5538 5282379
43
Tacrolimus Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 104987-11-3 445643 439492
44
Permethrin Approved, Investigational Phase 4 52645-53-1 40326
45
Dorzolamide Approved Phase 4 120279-96-1 3154 5284549
46
Sulfacetamide Approved Phase 4 144-80-9 5320
47
Benzocaine Approved Phase 4,Phase 3,Phase 1 1994-09-7, 94-09-7 2337
48
Travoprost Approved Phase 4,Phase 3 157283-68-6 5282226
49
Bimatoprost Approved, Investigational Phase 4,Phase 3,Early Phase 1 155206-00-1 5311027
50
Nepafenac Approved Phase 4,Phase 3,Phase 2 78281-72-8 151075

Interventional clinical trials:

(show top 50) (show all 1479)
id Name Status NCT ID Phase
1 Safety and Efficacy Study of Artificial Cornea Unknown status NCT01018888 Phase 4
2 The Impact of Topical Prostaglandins on the Biomechanical Properties of the Cornea in Patients With Open Angle Glaucoma Unknown status NCT02388360 Phase 4
3 Evaluating Results of Neusidl Corneal Inserter in Descemet's Stripping Automated Endothelial Keratoplasty (DSAEK) Unknown status NCT01357122 Phase 4
4 A Placebo Controlled Comparison of Topical Zirgan Versus Genteal Gel for the Treatment of Adenovirus Conjunctivitis Unknown status NCT01533480 Phase 4
5 Oral Nutrition Impact on Tear Film Unknown status NCT01561040 Phase 4
6 Evaluation of Changes in the Parameters of Optical Coherence Tomography After Intravitreal Injection of Lucentis Unknown status NCT01669447 Phase 4
7 Comparison of Efficacy, Safety and Anti-Inflammatory Effect Between Topical 0.05%Cyclosporine A Emulsion and REFRESH® in Patients With Moderate to Severe Dry Eyes Unknown status NCT00704275 Phase 4
8 Topical Cyclosporine for the Treatment of Dry Eye in Patients Infected With the Human Immunodeficiency Virus Unknown status NCT00797030 Phase 4
9 Altaire Gel Forming Solution Versus Refresh Tears for the Treatment of Dry Eye Signs and Symptoms Unknown status NCT01382810 Phase 4
10 Efficacy of FreshKote and Systane for the Treatment of Dry Eye and Improvement of Osmolarity Unknown status NCT01386073 Phase 4
11 A Placebo Controlled Double Masked Clinical Assessment Study of Essential Fatty Acid Supplement and Its Effect on Patients With Apparent Aqueous Deficient Dry Eye Syndrome Unknown status NCT00344721 Phase 4
12 Prospective Evaluation of Open-angle Glaucoma Subjects on Two Topical Hypotensive Medication Treated With Two iStents Unknown status NCT01252888 Phase 4
13 Purpose of This Study is to Evaluate the Safety and Efficacy of One, Two, or Three iStents for the Reduction of Intraocular Pressure in Open-angle Glaucoma Subjects Unknown status NCT01252849 Phase 4
14 Prospective Evaluation of Open-Angle Glaucoma Subjects on One Topical Hypotensive Medication Treated With Two iStents Unknown status NCT01252862 Phase 4
15 Effect of Posterior Corneal Toricity on Refractive Outcome of Pseudophakia Unknown status NCT01554761 Phase 4
16 Tear Film Evaluation After Phacoemulsification Unknown status NCT02238015 Phase 4
17 ALPI vs Medical Therapy Effects on Optic Nerve Structure & Function Unknown status NCT00485238 Phase 4
18 Efficacy of the Brand-name Latanoprost and One of Its Generic Version in Primary Open Angle Glaucoma and Ocular Hypertension Unknown status NCT02047630 Phase 4
19 Corneal Thickness Changes During Corneal Collagen Cross-linking With Ultraviolet-A Irradiation and Riboflavin Completed NCT01485211 Phase 4
20 Dermal Penetration of the Titanium Dioxide in Anthelios SX SPF40 Cream Completed NCT01021787 Phase 4
21 Ophthalmic Findings During 10-year Enzyme Substitution of Danish Fabry Patients. Completed NCT01997489 Phase 4
22 Comparison of Corticosteroid Dosing Regimens After Endothelial Keratoplasty Completed NCT01853696 Phase 4
23 Kynex Versus Refresh Plus Study in Subject With Dry Eye Completed NCT00809198 Phase 4
24 The Effects of Preservative-free Prostaglandin Eye Drops in Sign and Symptoms on the Eyes of Patients With Glaucoma Completed NCT01369771 Phase 4
25 The Utility of in Vivo Confocal Microscopy to Assess Cellular Response and Efficacy of Long-term Topical Steroid Treatment in Patients With Dry Eye Disease Completed NCT02120079 Phase 4
26 Effect on Wound Healing of Vigamox Versus Cravit Completed NCT00840580 Phase 4
27 Pain Management in Corneal Collagen Crosslinking for Keratoconus Completed NCT02867176 Phase 4
28 The Effect of Bevacizumab on Corneal Neovascularization Completed NCT00797303 Phase 4
29 Effect of Moisturising Creams on Skin Moisture in Atopic Dermatitis Completed NCT00846235 Phase 4
30 Corneal Staining and Physiological Compromise After Eight Hours of Soft Contact Lens Wear Completed NCT01015768 Phase 4
31 Partnership for Rapid Elimination of Trachoma Completed NCT00792922 Phase 4
32 Anterior Stromal Changes After PRK by Using Intraoperative Mitomicin C Completed NCT00599950 Phase 4
33 Role of Sub-Conjunctival Bevacizumab in Post Pterygium Excision Management Completed NCT01736449 Phase 4
34 Effects of Contact Lens Care Regimens on the Corneal Epithelium Completed NCT00349882 Phase 4
35 Comparison of Two Multi-Purpose Solution and Lens Material Combinations on Corneal Barrier Function Completed NCT00560898 Phase 4
36 Study of Azithromycin to Prevent Recurrent Trichiasis Following Surgery in Ethiopia Completed NCT00347776 Phase 4
37 Comparison of Toric IOL Implantation and Opposite Clear Corneal Incision During Cataract Surgery to Correct Corneal Astigmatism Completed NCT01763151 Phase 4
38 2-Site Safety Study of Besivance Versus Vigamox Prophylactically in Routine Cataract Surgery Completed NCT01455233 Phase 4
39 Mechanical vs. Alcohol Separation of the Corneal Epithelium During Surface Ablation Refractive Procedures Completed NCT00366808 Phase 4
40 Comparison of Functional Vision Provided by AMO Tecnis Z9000 and Alcon SA60AT Acrysof Completed NCT00459303 Phase 4
41 Soothe Versus Refresh Completed NCT00284999 Phase 4
42 Comparison of Ex-PRESSTM Mini Glaucoma Shunt to Trabeculectomy in Subjects With Open Angle Glaucoma Completed NCT00444080 Phase 4
43 Dropless™ vs. Less Drops™ Pharmaceutical Regimens After Cataract Surgery Completed NCT02819908 Phase 4
44 Povidone-iodine Antisepsis for Strabismus Surgery Completed NCT00461656 Phase 4
45 Effect of CACICOL20 on Corneal Epithelial Healing After Cross-linking in Patients With Keratoconus Completed NCT02119039 Phase 4
46 Corneal Endothelial Changes Associated With Phacoemulsification in Diabetes Mellitus Type II Completed NCT01078103 Phase 4
47 Study of the Presence and Extent of Corneal Disturbance Associated With B+L Biotrue MPS Used With B+L PureVision Lenses Completed NCT01268306 Phase 4
48 Intrastromal Corneal Ring Segment Implantation in 219 Keratoconic Eyes at Different Stages Completed NCT01261013 Phase 4
49 Comparison of DisCoVisc and Hydroxypropylmethylcellulose 2% Completed NCT01387620 Phase 4
50 Comparison Of Trabeculectomy Versus The Ex-PRESS Miniature Glaucoma Device In The Same Patient: A Prospective Randomized Study Completed NCT00698438 Phase 4

Search NIH Clinical Center for Corneal Disease

Inferred drug relations via UMLS 69 / NDF-RT 48 :


Cochrane evidence based reviews: corneal diseases

Genetic Tests for Corneal Disease

Anatomical Context for Corneal Disease

MalaCards organs/tissues related to Corneal Disease:

39
Eye, T Cells, Testes, Colon, Small Intestine

Publications for Corneal Disease

Articles related to Corneal Disease:

(show top 50) (show all 162)
id Title Authors Year
1
Keratoconus; a True Corneal Disease. ( 27195077 )
2016
2
Population-based assessment of vision-related quality of life in corneal disease: results from the CORE study. ( 26917676 )
2016
3
Reinhard T, Larkin F (eds), Corneal Disease 2013, ISBN: 978-3-642-28746-6, Springer. ( 26371062 )
2015
4
Comparing biometry in normal eyes of children with unilateral cataract/corneal disease to age-matched controls. ( 27363955 )
2015
5
Prior Corneal Scarification and Injection of Immune Serum are Not Required Before Ocular HSV-1 Infection for UV-B-Induced Virus Reactivation and Recurrent Herpetic Corneal Disease in Latently Infected Mice. ( 26398722 )
2015
6
Long-Term Results of the Boston Keratoprosthesis for Unilateral Corneal Disease. ( 26114818 )
2015
7
Evaluation of a low-cost design keratoprosthesis in end-stage corneal disease: a preliminary study. ( 26271267 )
2015
8
Partial lamellar keratoplasty for peripheral corneal disease using a graft from the glycerin-preserved corneoscleral rim. ( 24796771 )
2014
9
Telemedicine for corneal disease in rural Nepal. ( 24906650 )
2014
10
Cataract surgery in patients with corneal disease. ( 23197265 )
2013
11
Novel therapeutic approaches for corneal disease. ( 23725602 )
2013
12
Mosaic Chromosome 18q Partial Deletion Syndrome with Bilateral Full-thickness Corneal Disease: Surgical Intervention and Histopathology. ( 24024746 )
2013
13
Transmembrane water-flux through SLC4A11: a route defective in genetic corneal diseases. ( 23813972 )
2013
14
Keratocyte progenitor cell transplantation: A novel therapeutic strategy for corneal disease. ( 23200457 )
2013
15
Metaherpetic corneal disease in a dog associated with partial limbal stem cell deficiency and neurotrophic keratitis. ( 22958361 )
2013
16
Equine deep stromal abscesses (51 cases - 2004-2009) - Part 1: the clinical aspects with attention to the duration of the corneal disease, treatment history, clinical appearance, and microbiology results. ( 24131726 )
2013
17
A retrospective survey of the ocular histopathology of the pinniped eye with emphasis on corneal disease. ( 22812701 )
2013
18
Corneal disease in China. ( 22858025 )
2012
19
Correlation of clinical and pathologic diagnoses of corneal disease in penetrating keratoplasties in Vancouver: a 10-year review. ( 22333843 )
2012
20
Nerve growth factor therapy for corneal disease. ( 22543481 )
2012
21
Using soybean trypsin inhibitor as an external loading control for Western blot analysis of tear proteins: application to corneal disease. ( 22498032 )
2012
22
Suppression of transcription factor early growth response 1 reduces herpes simplex virus 1-induced corneal disease in mice. ( 22647700 )
2012
23
Pilot Study for OCT Guided Design and Fit of a Prosthetic Device for Treatment of Corneal Disease. ( 23316338 )
2012
24
Treatment of corneal disease with traditional Tibetan medicine: a report of four cases. ( 21505551 )
2011
25
B7 costimulation molecules encoded by replication-defective, vhs-deficient HSV-1 improve vaccine-induced protection against corneal disease. ( 21826207 )
2011
26
Intracorneal ring segments in ectatic corneal disease - a review. ( 20398105 )
2010
27
Pellucid marginal corneal disease in a case of atopic keratoconjunctivitis. ( 20482394 )
2010
28
Histopathology and treatment of corneal disease in keratitis, ichthyosis, and deafness (KID) syndrome. ( 19590522 )
2010
29
[Research and development for treating devastating corneal diseases]. ( 20387535 )
2010
30
Pattern of bilateral blinding corneal disease in patients waiting for keratoplasty in a tertiary eye care centre in northern India. ( 20118783 )
2010
31
Penetrating keratoplasty for unilateral corneal disease: outcomes from a tertiary care hospital in Australia. ( 19927002 )
2010
32
Parachlamydia acanthamoebae in domestic cats with and without corneal disease. ( 20618801 )
2010
33
Dystrophia Helsinglandica--corneal morphology, topography and sensitivity in a hereditary corneal disease with recurrent erosive episodes. ( 20597871 )
2010
34
Collagen cross-linking: a new treatment paradigm in corneal disease - a review. ( 20398104 )
2010
35
Age-related T-cell cytokine profile parallels corneal disease severity in Sjogren's syndrome-like keratoconjunctivitis sicca in CD25KO mice. ( 20007286 )
2010
36
Managing corneal disease: focus on suppurative keratitis. ( 20212926 )
2009
37
A new corneal disease with recurrent erosive episodes and autosomal-dominant inheritance. ( 18778339 )
2008
38
Disruption of CFTR-dependent lipid rafts reduces bacterial levels and corneal disease in a murine model of Pseudomonas aeruginosa keratitis. ( 18326723 )
2008
39
Mutation of the phospholipase catalytic domain of the Pseudomonas aeruginosa cytotoxin ExoU abolishes colonization promoting activity and reduces corneal disease severity. ( 17905228 )
2007
40
Apolipoprotein E alleles can contribute to the pathogenesis of numerous clinical conditions including HSV-1 corneal disease. ( 17007837 )
2007
41
Interleukin-10 (IL-10) ameliorates corneal disease in a mouse model of recurrent herpetic keratitis. ( 15652291 )
2005
42
Genetics of corneal disease for the ocular surface clinician. ( 17131020 )
2005
43
Feline corneal disease. ( 15948422 )
2005
44
Inherited corneal disease: the evolving molecular, genetic and imaging revolution. ( 15932539 )
2005
45
CD8(+) T cells control corneal disease following ocular infection with herpes simplex virus type 1. ( 15218191 )
2004
46
Clinical experience with butyl-2-cyanoacrylate adhesive in the management of canine and feline corneal disease. ( 15310291 )
2004
47
Distribution of TFF peptides in corneal disease and pterygium. ( 15177877 )
2004
48
Mouse genetic corneal disease resulting from transgenic insertional mutagenesis. ( 14977782 )
2004
49
Two patients with severe corneal disease in KID syndrome. ( 14700667 )
2004
50
Laser applications for corneal disease. ( 14604095 )
2003

Variations for Corneal Disease

Expression for Corneal Disease

Search GEO for disease gene expression data for Corneal Disease.

Pathways for Corneal Disease

Pathways related to Corneal Disease according to GeneCards Suite gene sharing:

id Super pathways Score Top Affiliating Genes
1 10.84 TACSTD2 TFF1 TGFBI

GO Terms for Corneal Disease

Cellular components related to Corneal Disease according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 extracellular region GO:0005576 9.65 COL8A2 GSN IL1A KERA LCAT NGF
2 proteinaceous extracellular matrix GO:0005578 9.56 COL8A2 KERA TFF3 TGFBI
3 extracellular space GO:0005615 9.28 GSN IL1A KERA LCAT TACSTD2 TFF1
4 connexin complex GO:0005922 9.16 GJB2 GJB6

Biological processes related to Corneal Disease according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 positive regulation of gene expression GO:0010628 9.56 GSN IL1A NGF TGFB2
2 inner ear development GO:0048839 9.33 GJB2 GJB6 TGFB2
3 wound healing GO:0042060 9.26 GSN TFF1 TFF3 TGFB2
4 visual perception GO:0007601 9.02 KERA KRT12 TACSTD2 TGFBI VSX1

Sources for Corneal Disease

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 MedGen
42 MeSH
43 MESH via Orphanet
44 MGI
46 NCI
47 NCIt
48 NDF-RT
51 NINDS
52 Novoseek
54 OMIM
55 OMIM via Orphanet
59 PubMed
60 QIAGEN
65 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....